Main Article Content
Background. The purpose was to study the histopathological features of steatosis, steatohepatitis and liver fibrosis in fatty liver disease of non-alcoholic etiology and to establish the linkages between the degree of steatosis, histological markers of fibrosis and increase of body mass index (BMI) in patients with non-alcoholic hepatic steatosis (NAHS) and non-alcoholic steatohepatitis (NASH) associated with obesity and pathology of the biliary tract. Materials and methods. The study included 70 patients with non-alcoholic fatty liver disease (NAFLD), including 48 individuals with NAHS combined with obesity (group 1), and 22 patients with NASH and obesity (group 2). Depending on the degree of increase in BMI, patients with NAHS, NASH and associated obesity were divided into three groups: BMI 25–29.9 kg/m2 — overweight; BMI 30–34.9 kg/m2 — I degree obesity; BMI 35–39.9 kg/m2 — II degree obesity. For histological diagnosis of NAHS/NASH, as well as to determine the stage of liver fibrosis, we used МЕТАVIR and BRUNT criteria. Results. The dependence of the severity of hepatic steatosis on BMI was detected in patients with different clinical forms of fatty liver disease, which was confirmed by the results of correlation analysis: NAHS — rs = 0.798 (p < 0.001), NASH — rs = 0.678 (p < 0.001). With increasing BMI, fibrous processes are exacerbated, from the presence of F0 stage in overweight patients with NAHS to F3 stage in II degree obesity in patients with NASH. The coefficients of correlation between BMI and the stage of liver fibrosis are: in NAHS — rs = 0.464 (p < 0.001), in NASH — rs = 0.759 (p < 0.001). Conclusions. In most cases of NAHS (58.3 %) and NASH (45.4 %,) macrovesicular steatosis was identified. Patients with NAHS more often had F1 and F2 fibrosis stages (50.0 %), while patients with NASH — F2 and F3 stages of fibrosis (77.3 %). Mixed type of liver fibrosis is characteristic of the comorbid course of NAFLD.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
Order of the Ministry of Health of Ukraine dated June 13, 2005 №271 "On Approval of Protocols for medical care for to Patients in the Field of Gastroenterology". Available from: http://www.moz.gov.ua/ua/portal/dn_20050613_271.html. (in Ukrainian).
Order of the Ministry of Health of Ukraine dated August 06, 2014 № 826 "Unified clinical protocol for primary, secondary (specialized) medical care "Non-alcoholic steatohepatitis". Available from: http://www.moz.gov.ua/ua/portal/dn_20141106_0826.html. (in Ukrainian).
Slinchenko NZ. Quick and lasting coloration of connective tissue, hyaline, fibrin and fibrinoid. Arkhiv patologii. 1964;2:84. (in Russian).
Stepanov YuM, Filippova OYu. Influence of body mass and associated pathology of the biliary tract on the development and progression of lipid disorders in patients with non-alcoholic fatty liver disease combined with obesity. Modern Gastroenterology. 2016;4(90):7-15. (in Ukrainian).
Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol. 2004 Sep;35(9):1070-82. PMID: 15343508.
Filippova A. Non-alcoholic steatohepatitis in patients with obesity: interconnection between body mass, changes of lipid metabolism and concomitant pathology of biliary tract. EUREKA: Health Sciences. 2016;4:3-11. doi: 10.21303/2504-5679.2016.00115.
WGO Practice Guideline – Obesity. 2011. Available from: http://www.worldgastroenterology.org/guidelines/global-guidelines/obesity.
Novakovic T, Mekic M, Smilic L, et. al. Anthropometric and Biochemical Characteristics of Patients with Nonalcoholic Fatty Liver Diagnosed by Non-Invasive Diagnostic Methods. Med Arch. 2014 Feb;68(1):22-6. doi: 10.5455/medarh.2014.68.22-26.
Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Lancet. 1997 Mar 22;349(9055):825-32. PMID: 9121257.